Skip to main navigation
Skip to main content
Skip to Footer
English
Français
Canada
Répertoire du site Sandoz
Our Work
What We Do
Quality Generics
Biopharmaceuticals
Specialty Products
About Us
Who We Are
Corporate Responsibility
Doing Business Responsibly
Contact Us
Grants, Donations and Sponsorships
Products
Consumers
Patients
Healthcare Professionals
Patient Support Programs
News
Media Releases
Media Resource Center
Stay Up-To-Date
Careers
Available Positions
Diversity & Inclusion
Our Benefits
Sandoz-Connect Portal
Search
Medicines
Medicines
Discovery
Hope
Global Impact
Education & Awareness
Medicines
Subscribe
New indication approved for Sandoz Erelzi® (etanercept) in the Treatment of Psoriatic Arthritis
Sandoz Canada has the necessary supply to ensure access to the S.O.S. Naloxone(TM) Hydrochloride Injection in response to the opioid crisis
Erelzi™ (etanercept), by Sandoz, is now available for patients in Canada for the treatment of multiple inflammatory diseases.
Bringing medication and medical care to people in crisis – the work of Americares
Sandoz Canada launches PrSandoz® Olmesartan for the treatment of high blood pressure
